MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX”) (TSX-V: MDX) announced today that Scott Spearn, an experienced medical device executive, joined the MedX team as President. Mr. Spearn has successfully built sales and distribution channels for medical devices across Canada, the United States and Latin America. His focus will be on developing and expanding MedX’s North American and international sales. Mr. Spearn will report to Robert von der Porten, CEO.
“With the completion of successful financings and the fact that we are well along the path to launching our telemedicine platform, MedX is well positioned to grow existing markets and enter new ones. Scott’s proven abilities and experience will play a significant role in getting MedX to the next level. We are very pleased that he is joining our team,” said Mr. von der Porten.
“I am very excited to be joining the Company because MedX’s SIAscope and laser technologies are exceptional and are helping change people’s lives for the better. I am excited about being part of the MedX team and to help grow its business on a global basis,” Mr. Spearn said.
About MedX
MedX, headquartered in Mississauga, Ontario, is a leading medical device company focused on skin cancer with its SIAscopy technology that is imbedded in its products SIAMETRICS™, SIMSYS™, and MoleMate™, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS™, SIMSYS™, and MoleMate™ include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are Health Canada, FDA (US), ARTG and CE cleared for use in Canada, the US, Australia, New Zealand, the European Union and Turkey. MedX also designs, manufactures and distributes quality laser and light therapy technologies to provide drug free and non-invasive treatment of tissue damage and pain. www.medxhealth.com.
